Revvity (RVTY) – Investment Analysts’ Weekly Ratings Changes

Revvity (NYSE: RVTY) recently received a number of ratings updates from brokerages and research firms:

  • 11/16/2026 – Revvity had its “overweight” rating reaffirmed by KeyCorp. They now have a $200.00 price target on the stock.
  • 11/16/2026 – Revvity had its price target raised by JPMorgan Chase & Co. from $160.00 to $165.00. They now have a “neutral” rating on the stock.
  • 11/14/2026 – Revvity was upgraded by Wall Street Zen from “hold” to “buy”.
  • 11/12/2026 – Revvity had its “market perform” rating reaffirmed by Sanford C. Bernstein.
  • 11/11/2026 – Revvity was upgraded by Weiss Ratings from “hold (c)” to “hold (c+)”.
  • 11/4/2026 – Revvity had its “neutral” rating reaffirmed by Bank of America.
  • 11/4/2026 – Revvity had its price target raised by JPMorgan Chase & Co. from $155.00 to $160.00. They now have a “neutral” rating on the stock.
  • 11/4/2026 – Revvity had its price target raised by TD Cowen from $175.00 to $185.00. They now have a “buy” rating on the stock.
  • 11/4/2026 – Revvity had its price target raised by Barclays from $160.00 to $175.00. They now have an “equal weight” rating on the stock.
  • 11/4/2026 – Revvity had its price target raised by Royal Bank Of Canada from $135.00 to $172.00. They now have a “sector perform” rating on the stock.
  • 11/4/2026 – Revvity was upgraded by Cfra from “hold” to “buy”.
  • 10/13/2026 – Revvity had its price target raised by TD Cowen from $130.00 to $175.00. They now have a “buy” rating on the stock.
  • 10/8/2026 – Revvity was upgraded by Weiss Ratings from “hold (c-)” to “hold (c)”.
  • 10/7/2026 – Revvity had its price target raised by Barclays from $115.00 to $160.00. They now have an “equal weight” rating on the stock.
  • 10/5/2026 – Revvity is now covered by William Blair. They set an “outperform” rating on the stock.

Revvity Price Performance

RVTY stock traded down $0.90 during mid-day trading on Tuesday, hitting $147.95. 1,511,058 shares of the stock were exchanged, compared to its average volume of 1,541,748. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.65 and a quick ratio of 2.10. The business has a fifty day moving average price of $150.85 and a 200 day moving average price of $114.48. Revvity Inc. has a 12 month low of $81.22 and a 12 month high of $171.74. The stock has a market capitalization of $16.52 billion, a price-to-earnings ratio of 65.46, a PEG ratio of 2.75 and a beta of 1.08.

Revvity (NYSE:RVTY – Get Free Report) last announced its quarterly earnings data on Tuesday, November 3rd. The company reported $1.38 earnings per share for the quarter, beating analysts’ consensus estimates of $1.30 by $0.08. Revvity had a return on equity of 8.64% and a net margin of 8.61%. The company had revenue of $728.90 million for the quarter, compared to analysts’ expectations of $694.73 million. During the same period last year, the firm posted $1.18 EPS. Revvity’s revenue for the quarter was up 4.3% compared to the same quarter last year. On average, sell-side analysts anticipate that Revvity Inc. will post 5.42 EPS for the current year.

Revvity Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 12th. Investors of record on Friday, January 22nd will be given a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a yield of 0.2%. The ex-dividend date is Friday, January 22nd. Revvity’s dividend payout ratio (DPR) is presently 12.39%.

Insider Transactions at Revvity

In related news, insider Maxwell Krakowiak sold 1,631 shares of the business’s stock in a transaction dated Monday, September 21st. The stock was sold at an average price of $144.53, for a total transaction of $235,728.43. Following the transaction, the insider owned 14,781 shares in the company, valued at $2,136,297.93. The trade was a 9.94% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Tajinder S. Vohra sold 7,330 shares of the stock in a transaction that occurred on Wednesday, September 16th. The stock was sold at an average price of $140.88, for a total value of $1,032,650.40. Following the completion of the sale, the insider owned 6,635 shares of the company’s stock, valued at approximately $934,738.80. This trade represents a 52.49% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 9,045 shares of company stock worth $1,281,439 in the last 90 days. Corporate insiders own 0.85% of the company’s stock.

Revvity, Inc. develops and supplies products and services for life sciences research and clinical diagnostics. Its offerings include instruments, reagents, software and related services used by pharmaceutical and biotechnology companies, academic and government research institutions, hospitals and clinical laboratories. The company’s work spans areas such as drug discovery and development, genetic testing, newborn screening and other diagnostic applications. Its technologies help researchers and healthcare providers analyze biological samples and generate information used in research and patient care.

Read More

Receive News & Ratings for Revvity Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity Inc and related companies with MarketBeat.com's FREE daily email newsletter.